Learn More About The 2026 Summit
This January, join 80+ ocular experts to explore long-acting intravitreal and subretinal innovations, emerging suprachoroidal techniques, novel formulation strategies, drug-device integration, and evolving regulatory expectations at the 4th Ophthalmic Drug Delivery Summit.
Learn more about why you should connect with trailblazers from firms like Genentech, Re-Vana Therapeutics, Adverum, Regeneron, and more - leaders redefining how novel technologies are shaping ocular drug delivery.